Scoggins Christopher J 4
4 · ABBOTT LABORATORIES · Filed Feb 3, 2021
Insider Transaction Report
Form 4
Scoggins Christopher J
EXECUTIVE VICE PRESIDENT
Transactions
- Exercise/Conversion
Common shares without par value
2021-02-01$38.40/sh+15,000$576,000→ 84,706 total - Exercise/Conversion
Option (right to buy)
2021-02-01−30,000→ 17,226 totalExercise: $48.04From: 2018-06-15Exp: 2025-06-14→ Common Shares (30,000 underlying) - Exercise/Conversion
Common shares without par value
2021-02-01$48.04/sh+30,000$1,441,200→ 69,706 total - Sale
Common shares without par value
2021-02-01$123.24/sh−45,000$5,545,800→ 39,706 total - Exercise/Conversion
Option (right to buy)
2021-02-01−15,000→ 0 totalExercise: $38.40From: 2019-02-19Exp: 2026-02-18→ Common Shares (15,000 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.